Santi Suryani

发表

Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts

A. Letai, P. Houghton, M. Cowley, 2014, Clinical Cancer Research.

DETERMINANTS OF IN VIVO EFFICACY OF THE BH 3 1 MIMETIC ABT-263 AGAINST PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA 2 XENOGRAFTS 3 4

A. Letai, P. Houghton, M. Cowley, 2014 .

Personalized Medicine and Imaging Cell and Molecular Determinants of In Vivo Ef fi cacy of the BH 3 MimeticABT-263 against PediatricAcute Lymphoblastic Leukemia Xenografts

A. Letai, P. Houghton, M. Cowley, 2014 .

B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans

Sami Al-Hajjar, J. Casanova, S. Choo, 2010, The Journal of experimental medicine.

Early commitment of naïve human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL‐12

S. Tangye, E. Deenick, D. Avery, 2009, Immunology and cell biology.

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling

G. Berx, F. Speleman, J. Soulier, 2015, Nature Communications.

An interferon-γ-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis

S. Suryani, I. Sutton, Santi Suryani, 2007, Journal of Neuroimmunology.

Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.

S. Tangye, S. Suryani, M. Wong, 2010, Blood.

Therapeutic implications of advances in our understanding of transitional B-cell development in humans

S. Tangye, S. Suryani, Santi Suryani, 2010, Expert review of clinical immunology.

Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia.

P. Houghton, A. Roberts, R. Lock, 2016, Blood.

MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation

D. Beck, J. Wong, Yizhou Huang, 2016, Leukemia.

Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia

M. Loh, C. Mullighan, P. Houghton, 2014, Molecular Cancer Therapeutics.

Evaluationof the InVitro and InVivo Ef fi cacyof the JAK Inhibitor AZD 1480 against JAK-Mutated Acute Lymphoblastic Leukemia

M. Loh, C. Mullighan, P. Houghton, 2015 .

Evaluation of the In Vitro and In Vivo Ef ﬁ cacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia

M. Loh, C. Mullighan, P. Houghton, 2015 .

Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts

A. Letai, P. Houghton, M. Cowley, 2014, Clinical Cancer Research.

Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome.

J. Ziegler, S. Tangye, J. Church, 2012, The Journal of allergy and clinical immunology.

Immune deficiencies , infection , and systemic immune disorders Clinical , molecular , and cellular immunologic findings in patients with SP 110-associated veno-occlusive disease with immunodeficiency syndrome

J. Ziegler, S. Tangye, J. Church, 2012 .

Biocontrol Delivery System of Trichoderma harzianum Formulated in Graphite and Silica Nano Particles to Control Rhizoctonia solani on Tomato Plants

I. Joni, S. Suryani, Hersanti, 2021, Materials Science Forum.